These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6235893)

  • 1. Free and conjugated GABA in human cerebrospinal fluid: effect of degenerative neurologic diseases and isoniazid.
    Manyam BV; Tremblay RD
    Brain Res; 1984 Jul; 307(1-2):217-23. PubMed ID: 6235893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders.
    Manyam NV; Katz L; Hare TA; Gerber JC; Grossman MH
    Arch Neurol; 1980 Jun; 37(6):352-5. PubMed ID: 6446278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid gamma-aminobutyric acid in neurologic disease.
    Achar VS; Welch KM; Chabi E; Bartosh K; Meyer JS
    Neurology; 1976 Aug; 26(8):777-80. PubMed ID: 133299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-aminobutyric acid (GABA) in cerebrospinal fluid.
    Kuroda H
    Acta Med Okayama; 1983 Jun; 37(3):167-77. PubMed ID: 6224397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea.
    Bonnet AM; Tell G; Schechter PJ; Grove J; Saint-Hilaire MH; De Smet Y; Agid Y
    Mov Disord; 1987; 2(2):117-23. PubMed ID: 2973560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further characterization of in vitro conditions appropriate for GABA determination in human CSF: impact of acid deproteinization and freeze/thaw.
    Ferraro TN; Manyam BV; Hare TA
    J Neurochem; 1983 Oct; 41(4):1057-64. PubMed ID: 6225837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human CSF GABA concentrations: revised downward for controls, but not decreased in Huntington's chorea.
    Perry TL; Hansen S; Wall RA; Gauthier SG
    J Neurochem; 1982 Mar; 38(3):766-73. PubMed ID: 6460090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free and conjugated CSF and plasma GABA in Huntington's chorea.
    Uhlhaas S; Lange H; Wappenschmidt J; Olek K
    Acta Neurol Scand; 1986 Oct; 74(4):261-5. PubMed ID: 3028028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid gamma-aminobutyric acid variations in neurological disorders.
    Enna SJ; Stern LZ; Wastek GJ; Yamamura HI
    Arch Neurol; 1977 Nov; 34(11):683-5. PubMed ID: 143928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid GABA levels in various neurological and psychiatric diseases.
    Kuroda H; Ogawa N; Yamawaki Y; Nukina I; Ofuji T; Yamamoto M; Otsuki S
    J Neurol Neurosurg Psychiatry; 1982 Mar; 45(3):257-60. PubMed ID: 7086447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CSF iron in patients with neurological diseases.
    Kjellin KG
    Acta Neurol Scand; 1967; 43(3):299-313. PubMed ID: 4227818
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of isoniazid on cerebrospinal fluid and plasma GABA levels in Huntington's disease.
    Manyam NV; Hare TA; Katz L
    Life Sci; 1980 Apr; 26(16):1303-8. PubMed ID: 6446011
    [No Abstract]   [Full Text] [Related]  

  • 13. GABA levels in cerebrospinal fluid of patients with epilepsy.
    Yamamoto M; Takahashi S; Otsuki S; Kugoh T; Hosokawa K; Ogawa N
    Folia Psychiatr Neurol Jpn; 1985; 39(4):515-9. PubMed ID: 3938765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoniazid-induced elevation of CSF GABA levels and effects on chorea in Huntington's disease.
    Manyam BV; Katz L; Hare TA; Kaniefski K; Tremblay RD
    Ann Neurol; 1981 Jul; 10(1):35-7. PubMed ID: 6455963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Huntington's disease. Cerebrospinal fluid GABA levels in at-risk individuals.
    Manyam NV; Hare TA; Katz L; Glaeser BS
    Arch Neurol; 1978 Nov; 35(11):728-30. PubMed ID: 152621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoniazid-induced alteration of CSF neurotransmitter amino acids in Huntington's disease.
    Manyam BV; Ferraro TN; Hare TA
    Brain Res; 1987 Apr; 408(1-2):125-30. PubMed ID: 2885064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid acetylcholinesterase and choline measurements in Huntington's disease.
    Manyam BV; Giacobini E; Colliver JA
    J Neurol; 1990 Aug; 237(5):281-4. PubMed ID: 2146369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of freezing on gamma-aminobutyric acid levels in human cerebrospinal fluid.
    Abbott RJ; Keidan J; Pye IF; Nahorski SR
    J Neurochem; 1981 Oct; 37(4):1042-4. PubMed ID: 7320717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma-aminobutyric acid levels in cerebrospinal fluid in neuropaediatric disorders.
    Cortès-Saladelafont E; Molero-Luis M; Cuadras D; Casado M; Armstrong-Morón J; Yubero D; Montoya J; Artuch R; García-Cazorla À;
    Dev Med Child Neurol; 2018 Aug; 60(8):780-792. PubMed ID: 29577258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of gamma-aminobutyric acid in human brain may increase dopaminergic neuronal function.
    Perry TL; Ito M; Jones K; Hansen S
    Neurosci Lett; 1984 Sep; 50(1-3):67-71. PubMed ID: 6238245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.